Skip to main content
. 2022 Mar 9;10(3):410. doi: 10.3390/vaccines10030410

Table 1.

Sample characteristics.

Frequency (%) (n = 915)
Age 18–29 years 418 (45.7)
30–39 years 228 (24.9)
40–49 years 143 (15.6)
50–59 years 90 (9.8)
60 years or more 36 (3.9)
Marital status Married 457 (49.9)
Do you have children? Yes 433 (47.3)
Do you have a chronic disease? Yes 203 (22.2)
Do you Smoke? No 660 (72.1)
Ex-smoker 32 (3.5)
Yes 223 (24.4)
Educational level High school or less 66 (7.2)
Diploma 41 (4.5)
University student 168 (18.4)
Bachelor 586 (64.0)
Postgraduate 54 (5.9)
Household average monthly income Less than 500 JD 340 (37.2)
500–1000 JD 393 (43.0)
More than 1000 JD 182 (19.9)
Residence North region 87 (9.5)
South region 23 (2.5)
Zarqa 90 (9.8)
Middle region 50 (5.5)
Amman 631 (69.0)
Other 34 (3.7)
Side effects experienced from a COVID-19 vaccine No symptom 193 (21.1)
Mild 266 (29.1)
Moderate 323 (35.3)
Severe 133 (14.5)
Know someone who died due to COVID-19? Yes 677 (74.0)
Reported side effects due to
COVID-19 vaccine
Headache 501 (54.8)
Hyperthermia 517 (56.5)
Pain at site of injection 615 (67.2)
Muscle pain 275 (30.1)
Weakness 365 (39.9)
Spasm 356 (38.9)
Nausea 158 (17.3)
Rash 21 (2.3)
Chills 192 (21.0)
Water retention 22 (2.4)
No symptoms 155 (16.9)